ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1083

Something Ventured, Something Gained: Alternative Therapies For FMS and RA

Robert S. Katz1, Hannah Bond2, Jessica L. Polyak2, Lauren Kwan2, Alexandra Small3 and Susan Shott4, 1Rush Medical College, Chicago, IL, 2Rheumatology Associates, Chicago, IL, 3University of Illinois Medical School, Chicago, IL, 4Rush University Medical Center, Chicago, IL

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: fibromyalgia, medication and treatment options

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Fibromyalgia, Soft Tissue Disorders and Pain II

Session Type: Abstract Submissions (ACR)

Background/Purpose:   Many patients with rheumatologic diseases resort to unproven alternative therapies. We compared FMS and RA patients with respect to the use and effectiveness of alternative therapies.

 Methods: 211 office patients with FMS (150; 130 women and 20 men; mean age 51 + 12) or RA (61; 45 women and 16 men; mean age 55 + 15) completed a questionnaire about alternative therapies for treating FMS or RA. Patients rated therapies as 1 = not helpful, 2 = mildly helpful, 3 = moderately helpful, and 4 = very helpful. The chi-square test of association was done to compare FMS and RA patients with respect to percentages, and the two-sided Mann-Whitney test was done to compare them with respect to the ratings, using a 0.05 significance level.

 Results: Significantly higher percentages of FMS patients reported having used meditation (44% vs. 26%, p = 0.025), massage (76% vs. 58%, p = 0.020), diet changes (75% vs. 56%, p = 0.018), exercise (92% vs. 79%, p = 0.013), and physical therapy (59% vs. 39%, p = 0.017) compared to RA patients. FMS patients were also more likely to report having tried herbal supplements (47% vs. 31%), biofeedback (21% vs. 9%), and chiropractic treatment (43% vs. 31%) (ns). For FMS patients, the most helpful therapies were yoga, exercise, massage, physical therapy, water therapy, and a gluten-free diet (median ratings = 3), followed by meditation, diet changes, herbal supplements, vitamins/minerals, acupuncture, biofeedback/cognitive behavioral therapy, chiropractic treatment, and tai chi (median ratings = 2), with hypnosis as least helpful (median rating = 1). For RA patients, the most helpful therapies were chiropractic treatment and water therapy (median ratings = 4 and 3.5), followed by yoga, meditation, exercise, massage, biofeedback/cognitive behavioral therapy, physical therapy, and tai chi (median ratings = 3), and diet changes, herbal supplements, vitamins/minerals, acupuncture, and a gluten-free diet (median ratings = 2), with hypnosis as least helpful (median rating = 1). The efficacy ratings were significantly different for FMS and RA patients only for chiropractic treatment efficacy, with lower ratings reported by FMS patients (median 2 vs. 4, p = 0.007).

Conclusion:  FMS patients were more adventuresome than RA patients when it came to trying alternative therapies. Many of these therapies had high efficacy ratings for FMS and/or RA patients.


Disclosure:

R. S. Katz,
None;

H. Bond,
None;

J. L. Polyak,
None;

L. Kwan,
None;

A. Small,
None;

S. Shott,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/something-ventured-something-gained-alternative-therapies-for-fms-and-ra/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology